- Clone type
- Vector
- Applications
-
Molecular biology
- Product format
- Freeze-dried
Documentation
ATCC determines the biosafety level of a material based on our risk assessment as guided by the current edition of Biosafety in Microbiological and Biomedical Laboratories (BMBL), U.S. Department of Health and Human Services. It is your responsibility to understand the hazards associated with the material per your organization’s policies and procedures as well as any other applicable regulations as enforced by your local or national agencies.
Detailed product information
General
- Specific applications
-
integrating vectorvector permitting positive selection for inserts
Characteristics
- Comments
-
Restriction digests of the clone give the following sizes (kb): EcoRI--6.0; BamHI--4.3, 1.8; HindIII--6.0; PstI--6.0; KpnI--3.4, 2.7.Can be selected with 100 ug/ml ampicillin and/or 75 ug/ml spectinomycin. Permits positive selection because deletion of the aadA fragment is not viable.E. coli JS219 is MC1061 malPp delta534::lacIq.Integration vector permitting positive selection for inserts.Transcription of the replication primer RNA is regulated by the lacZpo promoter/operator. In the presence of lacIq, replication is entirely dependent on the presence of inducer.The repressible replication system permits temporary maintenance of the plasmid, construction of strains with stable integrants of vector derivatives, and recovery of sequences adjacent to cloned fragments.pAM35 (ATCC 77186) differs from pAM34 (ATCC 77185) by deletion of the DraII fragment in pAM34 carrying lacIq.The order of the major features in this plasmid is: lacZpo - ori - rom - transcription terminator - BamHI - MCS - XmaIII - aadA (spcR) - MCS - BamHI - transcription terminator - bla - lacIq.
- Mycoplasma contamination
- Not detected
Vector information
- Construct size (kb)
- 6.0
- Intact vector size
- 6.000
- Vector name
- pAM34 (plasmid)
- Type of vector
- plasmid
- Construction
- pBR322, R100.1, pCK1
- Host range
-
Escherichia coli
- Cloning sites
-
BamHI; SalI; PstI; SphI; XmaIII; HindIII; EcoRI; SacI; KpnI
- Insert detection
- T4gene32 ter
- Markers
-
spcR; ampR
- Polylinker sites
-
BamHI; SalI; PstI; SphI; HindIII; EcoRI; SacI; KpnI; BamHI
- Replicon
- pMB1
- Repressor gene
-
lacIq
Handling information
- Host
-
Escherichia coli JS219
- Medium
- Temperature
-
37°C
- Handling notes
-
Restriction digests of the clone give the following sizes (kb): EcoRI--6.0;
BamHI--4.3, 1.8; HindIII--6.0; PstI--6.0; KpnI--3.4, 2.7.
- ATCC staff
Integration vector permitting positive selection for inserts.
- Gene 105: 17-22, 1991
Transcription of the replication primer RNA is regulated by the lacZpo
promoter/operator. In the presence of lacIq, replication is entirely dependent
on the presence of inducer.
- Gene 105: 17-22, 1991
The repressible replication system permits temporary maintenance of the plasmid,
construction of strains with stable integrants of vector derivatives, and
recovery of sequences adjacent to cloned fragments.
- Gene 105: 17-22, 1991
Can be selected with 100 ug/mL ampicillin and/or 75 ug/mL spectinomycin.
Permits positive selection because deletion of the aadA fragment is not viable.
- Gene 105: 17-22, 1991
The order of the major features in this plasmid is: lacZpo - ori - rom -
transcription terminator - BamHI - MCS - XmaIII - aadA (spcR) - MCS - BamHI -
transcription terminator - bla - lacIq.
- Gene 105: 17-22, 1991
pAM35 (ATCC 77186) differs from pAM34 (ATCC 77185) by deletion of the DraII
fragment in pAM34 carrying lacIq.
- Gene 105: 17-22, 1991
E. coli JS219 is MC1061 malPp delta534::lacIq.
- Nucleic Acids Res. 16: 6327-6338, 1988
History
- Depositors
- J Bouche
- Cross references
-
GenBank M69063
Legal disclaimers
- Intended use
- This product is intended for laboratory research use only. It is not intended for any animal or human therapeutic use, any human or animal consumption, or any diagnostic use.
- Warranty
-
The product is provided 'AS IS' and the viability of ATCC® products is warranted for 30 days from the date of shipment, provided that the customer has stored and handled the product according to the information included on the product information sheet, website, and Certificate of Analysis. For living cultures, ATCC lists the media formulation and reagents that have been found to be effective for the product. While other unspecified media and reagents may also produce satisfactory results, a change in the ATCC and/or depositor-recommended protocols may affect the recovery, growth, and/or function of the product. If an alternative medium formulation or reagent is used, the ATCC warranty for viability is no longer valid. Except as expressly set forth herein, no other warranties of any kind are provided, express or implied, including, but not limited to, any implied warranties of merchantability, fitness for a particular purpose, manufacture according to cGMP standards, typicality, safety, accuracy, and/or noninfringement.
- Disclaimers
-
This product is intended for laboratory research use only. It is not intended for any animal or human therapeutic use, any human or animal consumption, or any diagnostic use. Any proposed commercial use is prohibited without a license from ATCC.
While ATCC uses reasonable efforts to include accurate and up-to-date information on this product sheet, ATCC makes no warranties or representations as to its accuracy. Citations from scientific literature and patents are provided for informational purposes only. ATCC does not warrant that such information has been confirmed to be accurate or complete and the customer bears the sole responsibility of confirming the accuracy and completeness of any such information.
This product is sent on the condition that the customer is responsible for and assumes all risk and responsibility in connection with the receipt, handling, storage, disposal, and use of the ATCC product including without limitation taking all appropriate safety and handling precautions to minimize health or environmental risk. As a condition of receiving the material, the customer agrees that any activity undertaken with the ATCC product and any progeny or modifications will be conducted in compliance with all applicable laws, regulations, and guidelines. This product is provided 'AS IS' with no representations or warranties whatsoever except as expressly set forth herein and in no event shall ATCC, its parents, subsidiaries, directors, officers, agents, employees, assigns, successors, and affiliates be liable for indirect, special, incidental, or consequential damages of any kind in connection with or arising out of the customer's use of the product. While reasonable effort is made to ensure authenticity and reliability of materials on deposit, ATCC is not liable for damages arising from the misidentification or misrepresentation of such materials.
Please see the material transfer agreement (MTA) for further details regarding the use of this product. The MTA is available at www.atcc.org.
Images
Frequently Asked Questions
References
Curated Citations
Gil D, Bouche JP. ColE1-type vectors with fully repressible replication. Gene 105: 17-22, 1991. PubMed: 1937005
For product-related inquiries and issues, contact Product Experience:
Hours of Operation
US Eastern Time